Literature DB >> 24532040

Knockdown of Hnrnpa0, a del(5q) gene, alters myeloid cell fate in murine cells through regulation of AU-rich transcripts.

David J Young1, Angela Stoddart2, Joy Nakitandwe3, Shann-Ching Chen3, Zhijian Qian4, James R Downing3, Michelle M Le Beau5.   

Abstract

The control of mRNA stability plays a central role in orchestrating gene-regulatory networks in hematopoietic cell growth, differentiation and tumorigenesis. HNRNPA0, which encodes an RNA-binding protein shown to regulate transcript stability via binding to the AU-rich elements of mRNAs, is located within the commonly deleted segment of 5q31.2 in myeloid neoplasms with a del(5q), and is expressed at haploinsufficient levels in these patients. We show that HNRNPA0 is normally highly expressed in hematopoietic stem cells and exhibits dynamic changes in expression during the course of differentiation. To model HNRNPA0 haploinsufficiency, we used RNAi interference in primary murine cells and an experimental cell system, and found that reduced Hnrnpa0 expression leads to a shift from monocytic towards granulocytic differentiation. Microarray-based global expression profiling revealed that Hnrnpa0 knockdown disproportionally impacts AU-rich containing transcripts and alters expression of myeloid specification genes. In therapy-related myeloid neoplasms with a del(5q), AU-rich containing mRNAs are enriched in transcripts that encode proteins associated with increased growth and proliferation. Our findings implicate haploinsufficiency of HNRNPA0 as one of the key initiating mutations in the pathogenesis of myeloid neoplasms with a del(5q), and suggest that therapies that target AU-rich elements warrant consideration in efforts to develop new mechanism-based treatment strategies. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24532040      PMCID: PMC4040907          DOI: 10.3324/haematol.2013.098657

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  39 in total

Review 1.  Post-transcriptional regulation in cancer.

Authors:  Yann Audic; Rebecca S Hartley
Journal:  Biol Cell       Date:  2004-09       Impact factor: 4.458

Review 2.  The AU-rich transcriptome: more than interferons and cytokines, and its role in disease.

Authors:  Khalid S A Khabar
Journal:  J Interferon Cytokine Res       Date:  2005-01       Impact factor: 2.607

Review 3.  MAPK signaling pathways in the regulation of hematopoiesis.

Authors:  Christian R Geest; Paul J Coffer
Journal:  J Leukoc Biol       Date:  2009-06-04       Impact factor: 4.962

4.  Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).

Authors:  F Lai; L A Godley; J Joslin; A A Fernald; J Liu; R Espinosa; N Zhao; L Pamintuan; B G Till; R A Larson; Z Qian; M M Le Beau
Journal:  Genomics       Date:  2001-01-15       Impact factor: 5.736

5.  Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1.

Authors:  Holger Karsunky; Hui Zeng; Thorsten Schmidt; Branko Zevnik; Reinhart Kluge; Kurt Werner Schmid; Ulrich Dührsen; Tarik Möröy
Journal:  Nat Genet       Date:  2002-01-28       Impact factor: 38.330

6.  Nitric oxide-p38 MAPK signaling stabilizes mRNA through AU-rich element-dependent and -independent mechanisms.

Authors:  Shuibang Wang; Jianhua Zhang; Yi Zhang; Steven Kern; Robert L Danner
Journal:  J Leukoc Biol       Date:  2008-01-24       Impact factor: 4.962

7.  Phosphorylation of C/EBPalpha inhibits granulopoiesis.

Authors:  Sarah E Ross; Hanna S Radomska; Bo Wu; Pu Zhang; Jonathon N Winnay; Laszlo Bajnok; Wendy S Wright; Fred Schaufele; Daniel G Tenen; Ormond A MacDougald
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  GSEA-P: a desktop application for Gene Set Enrichment Analysis.

Authors:  Aravind Subramanian; Heidi Kuehn; Joshua Gould; Pablo Tamayo; Jill P Mesirov
Journal:  Bioinformatics       Date:  2007-07-20       Impact factor: 6.937

9.  Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

Authors:  Andrea Pellagatti; Mario Cazzola; Aristoteles A N Giagounidis; Luca Malcovati; Matteo G Della Porta; Sally Killick; Lisa J Campbell; Li Wang; Cordelia F Langford; Carrie Fidler; David Oscier; Carlo Aul; James S Wainscoat; Jacqueline Boultwood
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

10.  p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts.

Authors:  Mathias A E Frevel; Tala Bakheet; Aristobolo M Silva; John G Hissong; Khalid S A Khabar; Bryan R G Williams
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

View more
  10 in total

Review 1.  Therapy-related myeloid neoplasms: when genetics and environment collide.

Authors:  Megan E McNerney; Lucy A Godley; Michelle M Le Beau
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

2.  Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.

Authors:  Roberta La Starza; Gianluca Barba; Sofie Demeyer; Valentina Pierini; Danika Di Giacomo; Valentina Gianfelici; Claire Schwab; Caterina Matteucci; Carmen Vicente; Jan Cools; Monica Messina; Barbara Crescenzi; Sabina Chiaretti; Robin Foà; Giuseppe Basso; Christine J Harrison; Cristina Mecucci
Journal:  Haematologica       Date:  2016-05-05       Impact factor: 9.941

Review 3.  Building robust transcriptomes with master splicing factors.

Authors:  Mohini Jangi; Phillip A Sharp
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

4.  Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells.

Authors:  Tuoen Liu; Kilannin Krysiak; Cara Lunn Shirai; Sanghyun Kim; Jin Shao; Matthew Ndonwi; Matthew J Walter
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

5.  A global screening identifies chromatin-enriched RNA-binding proteins and the transcriptional regulatory activity of QKI5 during monocytic differentiation.

Authors:  Yue Ren; Yue Huo; Weiqian Li; Manman He; Siqi Liu; Jiabin Yang; Hongmei Zhao; Lingjie Xu; Yuehong Guo; Yanmin Si; Hualu Zhao; Shuan Rao; Jing Wang; Yanni Ma; Xiaoshuang Wang; Jia Yu; Fang Wang
Journal:  Genome Biol       Date:  2021-10-14       Impact factor: 13.583

6.  LncRNA miR205HG hinders HNRNPA0 translation: anti-oncogenic effects in esophageal carcinoma.

Authors:  Xiaoying Dong; Xuyuan Chen; Di Lu; Dingwei Diao; Xiguang Liu; Shijie Mai; Siyang Feng; Gang Xiong
Journal:  Mol Oncol       Date:  2021-12-20       Impact factor: 7.449

Review 7.  Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process.

Authors:  Nathalie Douet-Guilbert; Benoît Soubise; Delphine G Bernard; Marie-Bérengère Troadec
Journal:  Diagnostics (Basel)       Date:  2022-07-07

Review 8.  Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets.

Authors:  Ya Lu; Xinyue Wang; Quan Gu; Juan Wang; Ying Sui; Jianzhong Wu; Jifeng Feng
Journal:  Cell Death Discov       Date:  2022-07-25

9.  Integrative Cistromic and Transcriptomic Analyses Identify CREB Target Genes in Cystic Renal Epithelial Cells.

Authors:  Zhiheng Liu; Yunjing Liu; Lin Dang; Meijuan Geng; Yongzhan Sun; Yi Lu; Zhongze Fang; Hui Xiong; Yupeng Chen
Journal:  J Am Soc Nephrol       Date:  2021-06-23       Impact factor: 14.978

10.  Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Filipi Nascimento Silva; Luciano da Fontoura Costa; Leandro Rodrigues Ferreira; Glaucio Furlanetto; Paulo Chacur; Maria Claudia Nogueira Zerbini; Magda Carneiro-Sampaio
Journal:  Oncotarget       Date:  2016-02-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.